| Overview |
| bsm-61215r-TR |
| LIN28B Recombinant Antibody |
| WB, FCM, IF(ICC), IP |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Lin 28B |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 389421 |
| Q6ZN17 |
| Cytoplasm, Nucleus |
| CSDD2; FLJ16517; LIN28B; Protein lin-28 homolog B. |
| Suppressor of microRNA (miRNA) biogenesis, including that of let-7 and possibly of miR107, miR-143 and miR-200c. Binds primary let-7 transcripts (pri-let-7), including pri-let-7g and pri-let-7a-1, and sequester them in the nucleolus, away from the microprocessor complex, hence preventing their processing into mature miRNA. |
| Application Dilution |
| WB |
1:500-2000 |
| FCM |
FCM1:50-100 |
| IF(ICC) |
IFICC1:50-200 |
| IP |
IP1:20-50 |